Hans-Peter Hasler is a Swiss businessperson who founded Vicarius Pharma AG and who has been at the helm of 7 different companies. Presently, he occupies the position of Non-Executive Chairman for Shield Therapeutics Plc, Chairman at Medical Imaging Analysis Center and Chairman for HBM Healthcare Investments AG. Mr. Hasler is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA, Vicarius Pharma AG (former Chief Executive Officer & Director) and Gain Therapeutics, Inc. and Principal at Hph Management GmbH.
In his past career Hans-Peter Hasler occupied the position of Managing Director at Wyeth-lederle Pharma GmbH, Chief Operating Officer & Executive Vice President for Biogen, Inc. Chief Operating Officer for Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer of Elan Corp. Plc, Chief Marketing Officer for Wyeth Corp. and Chief Marketing Officer & Senior Vice President at Wyeth Pharmaceuticals LLC.
He received an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.